Infliximab-Associated Hepatic Failure in Ulcerative ColitisInfliximab-Associated Hepatic Failure in Ulcerative Colitis
While a rare occurrence, this report calls attention to a potentially lethal adverse effect of infliximab, underscoring the need to rule out pre-existing liver disease before initiating IFX therapy. Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Gastroenterology | Health | Inflammatory Bowel Disease | Liver | Liver Disease | Remicade | Ulcerative Colitis | Urology & Nephrology